Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 10 Breast Neoplasms 8 Carcinoma, Non-Small-Cell Lung 5 Neoplasms 4 Head and Neck Neoplasms 4 Melanoma 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Central Nervous System Neoplasms 3 Uterine Cervical Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 2 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Oligodendroglioma 2 Glioma 2 Glioblastoma 2 Ependymoma 2 Carcinoma, Renal Cell 2 Astrocytoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Thymus Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Sarcoma, Ewing 1 Sarcoma 1 Salivary Gland Neoplasms 1

Interventions

Cyclophosphamide 25 Temozolomide 22 Vincristine 18 Irinotecan 18 Doxorubicin 13 Topotecan 10 Melphalan 10 Etoposide 10 Ifosfamide 8 Busulfan 8 cabozantinib 7 Magnetic Resonance Spectroscopy 7 Granulocyte Colony-Stimulating Factor 7 Filgrastim 6 regorafenib 5 fludarabine 5 X-Rays 5 Specimen Handling 5 Sirolimus 5 Radiotherapy 5 Gemcitabine 5 Drug Therapy 5 pegfilgrastim 4 palbociclib 4 liposomal doxorubicin 4 irinotecan sucrosofate 4 ganitumab 4 fludarabine phosphate 4 Trabectedin 4 Phantoms, Imaging 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × alovudine × Clear all

NCT04067115 2025-12-17

U01CA236220

Sarcoma Alliance for Research through Collaboration

Phase 1/2 Completed

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡